The lack of innovation across permanent birth control and front-end infertility over the past few decades has left women with limited and antiquated options. Our pipeline seeks to answer the call for improved standards of care as we bring to market in-office technologies that are safe, natural, and minimally invasive.
PERMANENT BIRTH CONTROL
Since surgical tubal ligation was first performed in the 1880s, it remains the only permanent birth control option for women. Although effective, surgery can be associated with scarring from incisions, increased safety risks resulting from use of anesthesia, complications from the surgery itself, and the need for recovery time.
When surgery is not a suitable option, many women use hormonal birth control, which can result in severe side effects and increased safety risks, particularly as a woman ages. See how we are pioneering a new way forward in permanent birth control for women.
In the US
Dr. Blumenthal discusses the benefits of FemBloc and how it answers the growing need for permanent birth control options.
Infertility has become a significant global problem with limited advancements for first-line treatment options. See how we are innovating a first-and-only approach to deliver sperm directly to where conception occurs.